Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma

Published:2022-06-01 Issue:6 Volume:158 Page:697
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Joshi Tejas P.¹,Duvic Madeleine²,Torres-Cabala Carlos A.²³,Tschen Jaime⁴

Affiliation:

1. School of Medicine, Baylor College of Medicine, Houston, Texas

2. Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston

3. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston

4. St Joseph Dermatopathology, Houston, Texas

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2790785/jamadermatology_joshi_2022_lo_220005_1654530057.4098.pdf

Reference5 articles.

1. Treatment of cutaneous pseudolymphoma: a systematic review.;Miguel;Acta Derm Venereol,2018

2. Cutaneous B cell pseudolymphoma treated with rituximab and methotrexate.;Besch-Stokes;Dermatol Online J,2021

3. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.;Beck;N Engl J Med,2014

4. Interleukin 13 is a B cell stimulating factor.;Defrance;J Exp Med,1994

5. Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients.;Espinosa;J Am Acad Dermatol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab;JAAD Case Reports;2024-04

2. Cutaneous pseudolymphoma successfully treated with dupilumab;European Journal of Dermatology;2023-06

3. Dupilumab in Inflammatory Skin Diseases: A Systematic Review;Biomolecules;2023-03-31

4. Antimalarials/doxycycline/steroids;Reactions Weekly;2023-01-21

5. Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review;Acta Dermato-Venereologica;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3